Heron Therapeutics, Inc.
HRTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000818033
No open-market purchases or sales by Heron Therapeutics, Inc. insiders were filed in the last 90 days; 163 institutions reported holding it in 13F filings for Q2 2026, worth $57.1M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Heron Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 149 | 3 | 141 | −5 |
| Shares | 98.8M | 16.5K | 118.4M | +19.6M (+19.8%) |
| Value | $114.7M | $19.0K | $121.9M | +$7.22M (+6.3%) |
3 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (14)
Institutions that held Heron Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Dakota Wealth Management | 53,315 | $54.9K | 0.00% |
| Wealth Enhancement Advisory Services, LLC | 37,611 | $38.7K | 0.00% |
| SG Americas Securities, LLC | 30,560 | $31.0K | 0.00% |
| Wealth Alliance | 20,000 | $20.6K | 0.00% |
| Manufacturers Life Insurance Company, The | 19,603 | $20.2K | 0.00% |
| Virtu Financial LLC | 15,629 | $16.0K | 0.00% |
| Capital Planning Advisors, LLC | 13,470 | $13.9K | 0.00% |
| Quantbot Technologies LP | 10,992 | $11.3K | 0.00% |
| HighTower Advisors, LLC | 10,760 | $11.0K | 0.00% |
| Envestnet Asset Management Inc | 10,132 | $10.4K | 0.00% |
| Qube Research & Technologies Ltd | 6,021 | $6.20K | 0.00% |
| Comerica Bank | 495 | $510 | 0.00% |
| IFP Advisors, Inc | 271 | $279 | 0.00% |
| Russell Investments Group, Ltd. | 200 | $206 | 0.00% |
Sold out (19)
Institutions that held Heron Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Jefferies Financial Group Inc. | 1,290,924 | $1.50M |
| XTX Topco Ltd | 407,825 | $473.1K |
| Fisher Asset Management, LLC | 349,239 | $405.1K |
| Squarepoint Ops LLC | 160,138 | $185.8K |
| UBS Asset Management Americas Inc | 110,752 | $167.2K |
| Point72 Middle East FZE | 67,821 | $78.7K |
| Y-Intercept (Hong Kong) Ltd | 66,326 | $76.9K |
| Two Sigma Investments, LP | 36,500 | $42.3K |
| Cubist Systematic Strategies, LLC | 35,258 | $40.9K |
| Cutter & CO Brokerage, Inc. | 10,180 | $11.8K |
| Simplex Trading, LLC | 9,224 | $10.0K |
| Group One Trading, L.P. | 7,959 | $9.23K |
| Headlands Technologies LLC | 2,643 | $3.07K |
| Northwestern Mutual Wealth Management Co | 1,000 | $1.16K |
| Bollard Group LLC | 956 | $1.00K |
| Farther Finance Advisors, LLC | 100 | $116 |
| NewSquare Capital LLC | 40 | $46 |
| Point72 Asset Management, L.P. | 22 | $26 |
| Sofos Investments, Inc. | 1 | – |
Not filed for Q3 2023 yet (3)
Institutions that held Heron Therapeutics, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| PFS Investments Inc. | 15,231 | $18.0K |
| Lumature Wealth Partners, LLC | 835 | $969 |
| Endurance Wealth Management, Inc. | 400 | $0 |